HPMA copolymers with pH-controlled release of doxorubicin in vitro cytotoxicity and in vivo antitumor activityULBRICH, K; ETRYCH, T; CHYTIL, P et al.Journal of controlled release. 2003, Vol 87, Num 1-3, pp 33-47, issn 0168-3659, 15 p.Conference Paper

Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals : In vitro effect of extra drug-free GlyPheLeuGly sequencesRIHOVA, B; STROHALM, J; HOVORKA, O et al.Journal of controlled release. 2008, Vol 127, Num 2, pp 110-120, issn 0168-3659, 11 p.Article

Polymeric anticancer drugs with pH-controlled activationULBRICH, K; ETRYCH, T; CHYTIL, P et al.International journal of pharmaceutics. 2004, Vol 277, Num 1-2, pp 63-72, issn 0378-5173, 10 p.Conference Paper

New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targetingCHYTIL, P; ETRYCH, T; KONAK, C et al.Journal of controlled release. 2008, Vol 127, Num 2, pp 121-130, issn 0168-3659, 10 p.Article

Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activationULBRICH, K; ETRYCH, T; CHYTIL, P et al.Journal of drug targeting. 2004, Vol 12, Num 8, pp 477-489, issn 1061-186X, 13 p.Article